The discovery and validation of new drug targets in cancer

Sara Courtneidge, Greg D. Plowman

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the tumor, and its nourishment through the growth of new blood vessels.

Original languageEnglish (US)
Pages (from-to)632-636
Number of pages5
JournalCurrent Opinion in Biotechnology
Volume9
Issue number6
DOIs
StatePublished - Dec 1998
Externally publishedYes

Fingerprint

Growth
Pharmaceutical Preparations
Neoplasms
Signal transduction
Genomic Instability
Blood vessels
Blood Vessels
Tumors
Signal Transduction
Therapeutics

ASJC Scopus subject areas

  • Biotechnology

Cite this

The discovery and validation of new drug targets in cancer. / Courtneidge, Sara; Plowman, Greg D.

In: Current Opinion in Biotechnology, Vol. 9, No. 6, 12.1998, p. 632-636.

Research output: Contribution to journalArticle

@article{451e2749622a4d8dacf0a17f7ebe4625,
title = "The discovery and validation of new drug targets in cancer",
abstract = "Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the tumor, and its nourishment through the growth of new blood vessels.",
author = "Sara Courtneidge and Plowman, {Greg D.}",
year = "1998",
month = "12",
doi = "10.1016/S0958-1669(98)80142-0",
language = "English (US)",
volume = "9",
pages = "632--636",
journal = "Current Opinion in Biotechnology",
issn = "0958-1669",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - The discovery and validation of new drug targets in cancer

AU - Courtneidge, Sara

AU - Plowman, Greg D.

PY - 1998/12

Y1 - 1998/12

N2 - Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the tumor, and its nourishment through the growth of new blood vessels.

AB - Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the tumor, and its nourishment through the growth of new blood vessels.

UR - http://www.scopus.com/inward/record.url?scp=0032402833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032402833&partnerID=8YFLogxK

U2 - 10.1016/S0958-1669(98)80142-0

DO - 10.1016/S0958-1669(98)80142-0

M3 - Article

C2 - 9889138

AN - SCOPUS:0032402833

VL - 9

SP - 632

EP - 636

JO - Current Opinion in Biotechnology

JF - Current Opinion in Biotechnology

SN - 0958-1669

IS - 6

ER -